Expression of genes and their responses to enzyme replacement therapy in a Fabry disease mouse model

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse Model 100%
• Replacement Therapy 100%
• Fabry Disease 100%
• Neutrophil Gelatinase Associated Lipocalin 80%
• Galactosidase 60%
• Wild Type Mouse 40%
• Biological Marker 40%
• Western Blot 20%
• Lysosome Storage Disease 20%
• Disease Exacerbation 20%
• Calcium Binding Protein 20%
• Inflammation 20%
• Combination Therapy 20%
• Glycosphingolipid 20%
• Amyloid Protein 20%

Biochemistry, Genetics and Molecular Biology

• Mouse Model 100%
• Fabry Disease 100%
• Lipocalin-2 80%
• Galactosidase 60%
• Wild Type Mouse 40%
• Blood Level 40%
• Metabolic Pathway 20%
• Wild Type 20%
• Serum Amyloid A1 20%
• S100A9 20%
• Lysosomal Storage Disease 20%
• Gene Expression 20%
• Upregulation 20%
• Real-Time Polymerase Chain Reaction 20%
• Microarrays 20%
• Western Blotting 20%

Immunology and Microbiology

• Lipocalin-2 100%
• Mouse Model 100%
• Wild Type Mouse 50%
• Blood Level 50%
• Real-Time Polymerase Chain Reaction 25%
• Western Blot 25%
• Upregulation 25%
• Gene Expression 25%
• Calcium Binding 25%
• Thrombospondin 2 25%
• Wild Type 25%
• Protein Binding 25%